NCT06735053Recruiting
Impact of Virtual Reality Physiotherapy on Multiple Sclerosis Patients
Experimental Study on the Impact of a Virtual Reality-Based Physiotherapy Program as a Complement to a Conventional Physiotherapy Program in Patients With Moderate to Severe Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 21 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to learn if virtual reality combined with conventional physiotherapy intervention works to treat moderate to severe multiple sclerosis persons. The main questions it aims to answer are: * Does the application of a virtual reality-based program along with conventional physiotherapy produces improvements compared to the application of conventional physiotherapy and placebo virtual reality in motor aspects of patients with multiple sclerosis? * Does the application of a virtual reality-based program along with conventional physiotherapy produces improvements compared to the application of conventional physiotherapy and placebo virtual reality in cognitive aspects of patients with multiple sclerosis Researchers will compare a virtual reality-based program along with conventional physiotherapy with a placebo virtual reality to see if virtual reality improve motor and cognitive aspects of multiple sclerosis. Participants will: * Visit the clinic twice a week for 10 weeks to receive a 1-hour session of virtual reality and conventional physiotherapy. * Be assessed using various scales and questionnaires at three different times: at the start of the study, at the end of the treatment, and 4 weeks after the study ends.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 26 (estimated)
- First submitted
- 11 Dec 2024
- Start date
- Feb 2025
- Primary completion date
- May 2025
- Lead sponsor
- European University of Madrid
- Diseases
- Multiple sclerosis
- NCT number
- NCT06735053
What you commit to
- Study type: Interventional
- Planned participants: 26
- From Feb 2025 to the primary completion date, May 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- To have suffered an exacerbation or hospitalization in the last 3 months before starting the assessment protocol, nor during the therapeutic intervention process.
- To have received a course of steroids, intravenously or orally, 6 months prior to the start of the assessment protocol and within the intervention period of the study duration.
Other illness
- Diagnosis of another neurological disease or musculoskeletal disorder other than MS.
- Diagnosis of any cardiovascular, respiratory or metabolic disease, or other conditions that may interfere with this study.
Other
- Visual disturbances not corrected by ocular devices.
Who the study is looking for
- Confirmed diagnosis of Multiple Sclerosis based on McDonald criteria, with an evolution time of more than two years.
- All patients with Multiple Sclerosis are included according to the Kurtzke Multiple Sclerosis Disability Status Scale (EDSS) (ANNEX II) with a score greater than or equal to 6.5 (Need of two types of support to walk -two canes, walker...- about 20 meters without resting).
- Stable medical treatment for at least six months prior to intervention.
- Absence of cognitive impairment, with ability to understand instructions and to obtain a score equal to or greater than 24 on the Minimental Test.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fundación Esclerosis Multiple Madrid (FEMM) Coordinator of this site? Confirm its status | Madrid | Spain | Recruiting |
| Asociación Mostoleña de Esclerosis Múltiple (AMDEM) Coordinator of this site? Confirm its status | Móstoles | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.